Skip to main content

Active Avoidance

  • Living reference work entry
  • First Online:
Encyclopedia of Psychopharmacology
  • 969 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  • Arnt J (1982) Pharmacological specificity of conditioned avoidance response inhibition in rats. Inhibition by neuroleptics and correlation to dopamine receptor blockade. Acta Pharmacol Toxicol 51:321–329

    Article  CAS  Google Scholar 

  • Cook L, Weidley E (1957) Behavioral effects of some psychopharmacological agents. Ann N Y Acad Sci 66:740–752

    Article  CAS  PubMed  Google Scholar 

  • Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D’Souza CD, Erdos J, McCance E, Rosenblatt W, Fingado C, Zoghbi SS, Baldwin RM, Seibyl JP, Krystal JH, Charney DS, Innis RB (1996) Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A 93:9235–9240

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  • Litman RE, Su TP, Potter WZ, Hong WW, Pickar D (1996) Idazoxan and response to typical neuroleptics in treatment-resistant schizophrenia. Comparison with the atypical neuroleptic, clozapine. Br J Psychiatry 168:571–579

    Article  CAS  PubMed  Google Scholar 

  • Schubert MH, Young KA, Hicks PB (2006) Galantamine improves cognition in schizophrenic patients stabilized on risperidone. Biol Psychiatry 60:530–533

    Article  CAS  PubMed  Google Scholar 

  • Seeman P, Lee T, Chau-Wong M, Wong K (1976) Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261:717–719

    Article  CAS  PubMed  Google Scholar 

  • Wadenberg M-L, Karlsson M (2007) Galantamine enhances antipsychotic-like effects of low dose risperidone, with beneficial extrapyramidal side effect profile, in rats. Schizophr Res 98:175–176

    Article  Google Scholar 

  • Wadenberg M-L, Ericson E, Magnusson O, Ahlenius S (1990) Suppression of conditioned avoidance behavior by the local application of (−)sulpiride into the ventral, but not the dorsal, striatum of the rat. Biol Psychiatry 28:297–307

    Article  CAS  PubMed  Google Scholar 

  • Wadenberg M-L, Soliman A, VanderSpek SC, Kapur S (2001) Dopamine D(2) receptor occupancy is a common mechanism underlying animal models of antipsychotics and their clinical effects. Neuropsychopharmacology 25:633–641

    Article  CAS  PubMed  Google Scholar 

  • Wadenberg M-L, Wiker C, Svensson TH (2007) Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence. Int J Neuropsychopharmacol 10:191–202

    Article  CAS  PubMed  Google Scholar 

  • Wadenberg M-L, Fjällström A-K, Federley M, Persson P, Stenqvist P (2011) Effects of adjunct galantamine to risperidone, or haloperidol, in animal models of antipsychotic activity and extrapyramidal side-effect liability; involvement of the cholinergic muscarinic receptor. Int J Neuropsychopharmacol 14:644–654

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marie-Louise G. Wadenberg .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Wadenberg, ML.G. (2014). Active Avoidance. In: Stolerman, I., Price, L. (eds) Encyclopedia of Psychopharmacology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-27772-6_136-2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-27772-6_136-2

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Online ISBN: 978-3-642-27772-6

  • eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences

Publish with us

Policies and ethics